Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

VentriPoint Diagnostics Ltd V.VPT

Alternate Symbol(s):  VPTDF

Ventripoint Diagnostics Ltd is a Canada-based medical device company. The Company is engaged in the development and commercialization of diagnostic tools that monitor patients with heart disease. It is developing a suite of applications for all heart diseases and imaging modalities, including congenital heart disease, pregnancy, pulmonary hypertension, COVID-19, imaging, and cardiotoxicity in oncology patients. The Company’s Ventripoint Medical System (VMS+) is a diagnostic aid that was developed to provide a point-of-care solution to better communicate the heart’s structure and function without the need for magnetic resonance imaging (MRI). VMS+ enhances ultrasound, providing three-dimensional (3D) technology that allows for visualization of all four chambers of the heart. The system’s proprietary Knowledge Based Reconstruction (KBR) technology creates 3D models of the heart and calculates volumes and ejection fractions equivalent to the gold-standard Magnetic resonance imaging (MRI).


TSXV:VPT - Post by User

Bullboard Posts
Comment by fivenineron Dec 01, 2017 9:38am
92 Views
Post# 27071109

RE:RE:You People Are FORGETTING That 1.18M In Opex Is NOT Real !!

RE:RE:You People Are FORGETTING That 1.18M In Opex Is NOT Real !!
Annayya wrote: Thanks Eigen. In the context of PP, I'd like to point out the following from MD&A. It seems like when we may run out of cash in March 2018, we can get up to $2.1 million from our China Partner. This money was expected in 2017 but because we already had so much cash on hand it was postponed and should be available anytime we need it in 2018.


Hilarious! 
Although, I do suppose this is technically true.
I also expect I will get that yellow power ranger for Christmas (damn Santa and his damn naughty list)

Know your history!

From Q3 2015 MD&A
The future investment into Ventripoint of C$2,250,000 will be made upon the completion of certain steps within the 90 days after the VMS machine is installed in a major Chinese hospital, and will be on terms to be determined by the parties, within the context of market conditions at the time.

Year End  2015 MD&A
Due to market conditions, the additional investment has been postponed

Q1 2016 MD&A
Due to market conditions, the additional investment has been postponed.

Q2 2016 MD&A
Due to market conditions, the additional investment has been postponed.

Q3 2016 MD&A
Due to market conditions, the additional investment has been postponed.

Year End 2016 MD&A
Due to market conditions and capital on hand, the additional investment has been postponed

Q1 2017 MD&A
Due to market conditions and capital on hand, the additional investment has been postponed.
Bullboard Posts